Home > Insider Trading > Filing (0001209191-17-038221)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1419600	Flexion Therapeutics Inc	FLXN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1597407	D. Michael Clayman	C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-05	5,000	$17.23	20,146	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	294,383	Indirect	By the Michael D.Clayman 2006 Revocable Trust
Common Stock	24,600	Indirect	By the Michael D. Clayman Irrevocable Trust
Common Stock	388,683	Indirect	By Versant Development Fund III, LLC

Footnotes

The weighted average purchase price for the transaction reported was $17.23030, and the range of prices were between $17.22580 and $17.23980. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.